MR Vaccines Market, by Vaccine Brand (MR Vaccine and MRBEV (BE LTD.), by Distribution Channel (Private and Public), and by Region (Commonwealth of Independent States (CIS) Countries, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 55.7 million in 2021 and is expected to exhibit a CAGR of 2.1% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Request Sample Report (Including Full TOC, Table & Figures) @
https://www.coherentmarketinsights.com/insight/request-sample/4917
Growing government initiatives to make MR vaccine available around the globe, via arranging vaccination campaign is projected to drive the market growth over the forecast period.
For instance, in November 2021, nationwide campaign was launched by the Pakistan government. An objective of this campaign was to immunize more than 90 million children in order to reduce incidences of measles and rubella disease across Pakistan.
Impact of Coronavirus (Covid-19) Pandemic
COVID-19 outbreak was first reported on December 31, 2019 in Wuhan, China. According to the Coronavirus (COVID-19), Weekly Epidemiological Update by the World Health Organization, over 265,194,191 cases and 5,254,116 deaths due to Coronavirus (COVID-19) were reported up till December 06, 2021, across the globe.
The COVID-19 pandemic has negatively affected several markets across the globe and has also hampered the demand and supply in MR vaccines market, owing to reduced access to immunization services during the COVID-19 outbreak.
Outbreaks of measles, increasing number of unvaccinated children, disease diagnostics, and detection deviated to support COVID-19 responses are the factors that raise the probability of severe measles-related complications and deaths in children.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4917
Key players involved in the market are focusing on adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions, in order to strengthen their position in the global market.
For instance, in June 2017, Takeda Pharmaceutical Company Limited, a Japanese multinational pharmaceutical company collaborated with Biological E. Limited (BE), an Indian biotechnology and biopharmaceutical company. This partnership aimed to develop low-cost combination vaccines for measles-rubella (MR) for low and middle-income countries such as Algeria, Bangladesh, Jordan, Iraq etc.
Key Takeaways of the MR Vaccines Market:
The MR vaccines market is expected to exhibit a CAGR of 2.1% over the forecast period, due to growing research and development activities to develop safe MR vaccines and government contribution to arrange vaccination campaigns
Among vaccine brand, MR vaccine segment is expected to account for largest market share during the forecast period, due to growing ongoing clinical trials to develop and launch novel and safe MR vaccine in the market
Key players operating in the MR vaccines market include PT Bio Farma, Bio-Manguinhos, BE Vaccines, Serum Institute of India, and Crucell Switzerland AG
Reasons to buy this MR Vaccines Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ MR Vaccines market size estimation and recent advancements in the industry are explained.
SPECIAL OFFER (Avail an Up-to 30% discount on this report ) @
https://www.coherentmarketinsights.com/insight/buy-now/4917
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Brand
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Therapy Assessment
- Disease Assessment
- Epidemiological Assessment
- Industry Assessment
- Market Dynamics
- MR Vaccines Market– Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- MR Vaccines Market, By Vaccine Brand, 2021 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- MR Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- MRBEV (BE LTD.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Introduction
- MR Vaccines Market, By Distribution Channel, 2021 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Introduction
- MR Vaccines Market, By Region, 2021 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2028
- Commonwealth of Independent States (CIS) Countries
- Market Size and Forecast, By Vaccine Brand, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Russia
- Uzbekistan
- Kazakhstan
- Ukraine
- Turkmenistan
- Belarus
- Armenia
- Latin America
- Market Size and Forecast, By Vaccine Brand, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Brazil
- Mexico
- Argentina
- Honduras
- Colombia
- Peru
- Chile
- Europe
- Market Size and Forecast, By Vaccine Brand, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Turkey
- Asia
- Market Size and Forecast, By Vaccine Brand, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Pakistan
- Indonesia
- Bangladesh
- Philippines
- Vietnam
- Thailand
- Myanmar
- Malaysia
- Cambodia
- Nepal
- Sri Lanka
- Papua New Guinea
- Mauritius
- Middle East
- Market Size and Forecast, By Vaccine Brand, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- UAE
- Israel
- Iraq
- Iran
- Saudi Arabia
- Jordan
- Qatar
- Oman
- Syrian Arab Republic
- Africa
- Market Size and Forecast, By Vaccine Brand, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Market Size and Forecast, By Region/Country, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)
- Nigeria
- Tanzania
- Democratic Republic of Congo
- Ethiopia
- Kenya
- South Africa
- Egypt
- Morocco
- Ghana
- Uganda
- Burkina Faso
- Angola
- Algeria
- Zimbabwe
- Tunisia
- Botswana
- Libya
- Namibia
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- PT Bio Farma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bio-Manguinhos
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Crucell Switzerland AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Serum Institute of India
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BE Vaccines
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PT Bio Farma
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837